Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication

The Journal of Clinical Investigation
J H Caldwell, N J Greenberger

Abstract

Previous studies have demonstrated that considerable amounts of parenterally administered cardiac glycosides are excreted in the bile and reabsorbed across the intestinal mucosa in several species. It is currently believed that the more prolonged action of nonpolar digitalis glycosides is due to their retention and recycling in the enterohepatic circulation. This report describes studies carried out to evaluate the effects of pharmacologic interruption of this enterohepatic cycle with the intraluminal sequestering agent cholestyramine. Cholestyramine was found to bind substantial quantities of digitoxin-(3)H and digoxin-(3)H in vitro and this binding was only modestly inhibited by the presence of bile. Administration of cholestyramine to rats by intragastric catheter before the subcutaneous injection of the LD(100) dose of digitoxin (10 mg/kg) resulted in a 70% survival rate. Further, oral administration of cholestyramine to rats before the subcutaneous injection of digitoxin-(3)H resulted in accelerated fecal excretion of radioactivity and lower levels of digitoxin-(3)H and metabolites in brain tissue compared to controls. Similarly, pretreatment of guinea pigs with cholestyramine orally before the injection of digitoxin in do...Continue Reading

References

Jun 1, 1968·The American Journal of the Medical Sciences·J E Doherty
Jun 9, 1969·JAMA : the Journal of the American Medical Association·R C NorthcuttE G Stant
Oct 1, 1965·Proceedings of the Society for Experimental Biology and Medicine·D G GalloA L Sheffner
Jan 26, 1963·British Medical Journal·D V DATTA, S SHERLOCK

Citations

Jul 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·J H CaldwellC W Beachler
Oct 1, 1973·The American Journal of Digestive Diseases·W G Thompson
Apr 15, 1982·Klinische Wochenschrift·T HessW Riesen
Apr 15, 1982·Experientia·H AllgayerG Paumgartner
Jul 1, 1982·Canadian Anaesthetists' Society Journal·P R GwiltJ J Mitala
Feb 16, 2002·Journal of Clinical Pharmacy and Therapeutics·S C ChienA T Chow
Nov 15, 1973·The New England Journal of Medicine·T W Smith, E Haber
Jan 8, 2005·The New England Journal of Medicine·Michael M Ritter
Aug 1, 1982·Journal of Toxicology and Environmental Health·T RozmanH Greim
Nov 1, 1975·Clinical and Experimental Pharmacology & Physiology·D Proppe
Sep 1, 1985·British Heart Journal·D A Chamberlain
Dec 1, 1978·Klinische Wochenschrift·H J GilfrichC J Schuster
Feb 1, 1975·Journal of Clinical Pharmacology·D E Hutcheon
Jan 1, 1982·Pharmacology & Therapeutics·K O Haustein
Apr 11, 1975·European Journal of Clinical Investigation·A Sedaghat, E H Ahrens
Jan 1, 1984·Drug Metabolism Reviews·Z H Israili, P G Dayton
Nov 1, 1982·Journal of Toxicology. Clinical Toxicology·D MathieuF Wattel
Jul 1, 1987·Diabetes/metabolism Reviews·M F Lopes-Virella, J A Colwell
May 1, 1985·Journal of the American College of Cardiology·F I Marcus
Nov 3, 2015·Toxicology and Applied Pharmacology·Xiaoxia YangJeffrey W Fisher
Aug 1, 2018·The Journal of Pharmacy and Pharmacology·Chara LitouJennifer B Dressman
Jan 1, 1984·Annals of the New York Academy of Sciences·J T Bigger, E G Giardina
Nov 22, 2005·Dermatologic Therapy·Malcolm W Greaves
Feb 1, 1988·British Journal of Clinical Pharmacology·P J NeuvonenE L Hirvisalo
Sep 1, 1984·British Journal of Clinical Pharmacology·D M HibbardD B Hunninghake
Jan 1, 1985·Journal of Toxicology. Clinical Toxicology·A SmolarzP Abshagen
Jan 1, 1981·Biomaterials, Medical Devices, and Artificial Organs·C J HollowayI Haeger
Dec 1, 1985·Drug Intelligence & Clinical Pharmacy·G D ParkP Roberts
Jan 1, 1983·Drug Intelligence & Clinical Pharmacy·A M BaciewiczG L Lipscomb
Oct 1, 1983·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C P SiegersC D Klaassen
Oct 1, 1975·CRC Critical Reviews in Toxicology·C D Klaassen
Apr 2, 2020·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Xia GongLingzhi Gong

Related Concepts

Biliary Sludge
MK-135
Thin Layer Chromatography
Digitoxin-Philo
Mapluxin
Cavia porcellus
Intestinal Absorption
Liver
Tritium

Related Feeds

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.